Aegis Capital Starts Revance Therapeutic (RVNC) at Buy; Likes Botulinum Opportunity
Go back to Aegis Capital Starts Revance Therapeutic (RVNC) at Buy; Likes Botulinum OpportunityREVANCE THERAP (NASDAQ: RVNC) | Delayed: 3.78 -0.01 (0.26%) | |||||
---|---|---|---|---|---|---|
Previous Close | $3.79 | 52 Week High | $41.12 | |||
Open | $3.80 | 52 Week Low | $12.35 | |||
Day High | $3.87 | P/E | N/A | |||
Day Low | $3.71 | EPS | $-27.14 | |||
Volume | 1,647,560 |